Metabolic dysfunction-associated liver disease – Diagnostics – Overview of Information and Clinical Research

Diagnosing metabolic dysfunction-associated steatotic liver disease often happens without warning, as most people feel perfectly fine until the condition advances. Understanding when to get tested and what tests healthcare providers use can help catch this common liver condition early, when lifestyle changes can still make a real difference.

Introduction: Who Should Seek Diagnostic Testing

Many people discover they have metabolic dysfunction-associated steatotic liver disease, or MASLD, completely by accident. Perhaps you went for an ultrasound for an unrelated reason, or your doctor noticed something unusual in routine blood work. This happens because MASLD often develops silently over many years without causing any noticeable symptoms.^[1]

If you have certain health conditions, your doctor may recommend testing for MASLD even if you feel perfectly well. People with obesity, especially those who carry extra weight around their belly, should consider getting checked. Having a body mass index (BMI) of 30 or higher puts you at increased risk. Similarly, if you have been diagnosed with type 2 diabetes, your chances of having MASLD are significantly higher.^[1]

Other metabolic conditions also warrant screening. If you have insulin resistance, which means your body’s cells don’t respond properly to insulin, you may be at risk. People with dyslipidemia, or abnormal levels of fats in the blood such as high cholesterol or high triglycerides, should also discuss testing with their healthcare provider. High blood pressure is another red flag that suggests screening might be appropriate.^[4]

Age matters too. Healthcare providers most commonly diagnose MASLD in people between 50 and 60 years old, though the condition is increasingly appearing in younger people, including teenagers, due to rising obesity rates.^[4] Given that experts estimate more than 30% of people worldwide have this condition, and it affects about 100 million people in the United States alone, early detection has become a critical public health concern.^[1]^[17]

⚠️ Important

You may have MASLD without any symptoms at all. Most people only notice changes in their body if the condition progresses to a more serious form called MASH, which causes inflammation and scarring. This is why screening is so important for people with risk factors, even when they feel perfectly healthy.

Classic Diagnostic Methods

When your healthcare provider suspects you might have MASLD, they will start with a thorough review of your medical history and a physical examination. During this conversation, they will ask about your overall health, any medications you take, and whether you consume alcohol. This helps them rule out other causes of liver disease, particularly alcohol-related liver damage, since MASLD specifically occurs in people who drink little to no alcohol.^[1]

Blood Tests

Blood tests are usually the first diagnostic step. Your doctor will order tests to check your liver enzyme levels, particularly enzymes called aspartate aminotransferase (AST) and alanine aminotransferase (ALT). When your liver is damaged or inflamed, these enzymes leak into your bloodstream, causing their levels to rise. However, it’s important to understand that having normal liver enzyme levels doesn’t rule out MASLD. Many people with the condition have completely normal blood test results.^[1]

Blood tests also help your provider assess other important factors. They will check your blood sugar levels, cholesterol, and triglycerides. These measurements not only help identify risk factors but also reveal how the condition might be affecting your overall metabolic health. Your doctor may also order tests to rule out other liver diseases, such as viral hepatitis or autoimmune liver conditions, which can sometimes look similar to MASLD.^[12]

Imaging Studies

Imaging tests allow doctors to actually see fat accumulation in your liver without needing surgery. Ultrasound is often the first imaging test used because it’s widely available, relatively inexpensive, and doesn’t expose you to radiation. During an ultrasound, sound waves create pictures of your liver, and fatty tissue appears different from normal liver tissue on the screen. This test can identify when fat makes up more than 5% to 10% of your liver’s weight, which is the threshold for diagnosing MASLD.^[3]^[19]

Other imaging options include computed tomography (CT) scans and magnetic resonance imaging (MRI). MRI is particularly good at measuring the exact amount of fat in your liver. There are specialized MRI techniques specifically designed to quantify liver fat, though these may not be available everywhere and tend to cost more than standard ultrasound.^[5]

Assessing Liver Scarring

Finding fat in your liver is just the first step. What really matters for your long-term health is whether that fat is causing scarring, also called fibrosis. Healthcare providers have several ways to assess this without performing surgery. One common approach uses blood tests to calculate what’s called a FIB-4 score. This calculation uses your age, liver enzyme levels, and platelet count (a type of blood cell) to estimate how much scarring you might have.^[3]

Another non-invasive tool is transient elastography, sometimes called a FibroScan. This special type of ultrasound measures how stiff your liver is. Healthy liver tissue is soft and flexible, but scarred tissue is stiffer. The test is quick, painless, and gives results immediately. It’s particularly useful for monitoring whether your liver scarring is getting better or worse over time.^[12]

Liver Biopsy

Sometimes, despite all these tests, your doctor may recommend a liver biopsy. This involves taking a small sample of liver tissue, usually with a needle inserted through your skin. The tissue sample is then examined under a microscope. A biopsy remains the most accurate way to diagnose MASLD and determine how severe it is, particularly when trying to distinguish simple fat accumulation from MASH, the more serious inflammatory form of the disease.^[4]

Biopsies are not routine for everyone with suspected MASLD. Your doctor typically recommends one only when other tests give unclear results, when they need to rule out other liver diseases, or when you might be a candidate for specific treatments. The procedure carries small risks, including bleeding and infection, so healthcare providers reserve it for situations where the information it provides will meaningfully change your treatment plan.^[12]

⚠️ Important

Having elevated liver enzymes in your blood tests does not necessarily mean you have severe liver disease. Similarly, normal liver enzyme levels don’t guarantee your liver is healthy. This is why healthcare providers use multiple different tests together to get the complete picture of your liver health.

Diagnostics for Clinical Trial Qualification

If you’re considering joining a clinical trial for MASLD treatment, you’ll undergo additional, more specific testing. Clinical trials test new medications and treatments, so researchers need very precise information about your liver condition to determine if you’re eligible and to measure whether the treatment works.

Clinical trials typically require confirmation that you have not just MASLD, but specifically MASH, the inflammatory form of the disease. Since MASH cannot be reliably diagnosed through blood tests or standard imaging alone, most trials require a liver biopsy before enrollment. The biopsy helps researchers grade the severity of inflammation and determine the stage of fibrosis in your liver. Many trials specifically look for people with moderate to severe fibrosis, classified as stage F2 or F3.^[4]^[10]

The biopsy tissue gets examined by a specialized doctor called a pathologist, who looks for specific features under the microscope. They assess three main things: how much fat is in your liver cells, whether there’s inflammation and damage to liver cells, and how much scarring has developed. This detailed examination follows standardized scoring systems that allow researchers to compare results across different patients and different studies.

Beyond the biopsy, clinical trials often require extensive blood work. This goes beyond routine liver enzyme tests to include detailed measurements of your metabolic health. Researchers will check your insulin levels, blood sugar control over time using a test called hemoglobin A1C, and detailed cholesterol profiles that break down different types of fats in your blood. They may also measure markers of inflammation throughout your body.^[8]

Some trials use advanced imaging techniques as well. Specialized MRI scans can precisely measure the percentage of fat in your liver and may be used to track changes during the study. Another advanced tool called MR elastography combines MRI with sound waves to measure liver stiffness, providing detailed information about scarring without requiring repeated biopsies.^[3]

Trials may also assess your overall health and function in ways beyond standard medical tests. Researchers might ask you to complete questionnaires about your quality of life, energy levels, and daily functioning. Some studies measure your body composition using special scans that determine how much of your weight is fat versus muscle. Physical fitness tests, like walking for six minutes or measuring your grip strength, might be included too.

The specific tests required vary depending on what the clinical trial is studying. If a trial tests a medication that aims to reduce liver fat, researchers will use precise imaging to measure changes. If the trial studies a drug meant to reduce fibrosis, repeat biopsies during or at the end of the study might be necessary to see if scarring has improved. Always discuss with the research team exactly what testing their specific trial requires before deciding whether to participate.

Prognosis and Survival Rate

Prognosis

The outlook for people with metabolic dysfunction-associated steatotic liver disease varies greatly depending on how far the condition has progressed and whether lifestyle changes or treatments are started early. Many people with simple fatty liver can see improvement or even complete reversal of their condition through weight loss, better diet, and regular exercise. Research shows that losing just 7% to 10% of total body weight can significantly reduce liver fat and improve overall liver health.^[13]

However, the prognosis becomes more serious when MASLD progresses to MASH, the inflammatory form of the disease. Some people with MASH develop worsening fibrosis that can advance to cirrhosis, a condition where extensive scarring severely damages the liver. Cirrhosis can lead to liver failure or liver cancer, particularly hepatocellular carcinoma. Once cirrhosis develops, reversing the damage becomes much more difficult, though stopping further progression is still possible with proper treatment.^[1]^[5]

It’s important to understand that MASLD affects more than just your liver. People with this condition face increased risks of cardiovascular disease, which is actually the leading cause of death in people with MASLD, not liver disease itself. The condition also raises the risk of developing type 2 diabetes in people who don’t already have it, as well as certain cancers including breast cancer and colorectal cancer.^[1]^[17]

Survival rate

Life expectancy with MASLD depends heavily on whether you have simple fatty liver or the more advanced MASH form, and particularly on the degree of liver scarring present. People with MASLD who have minimal or no fibrosis generally have a good prognosis and near-normal life expectancy if they manage their metabolic conditions and make lifestyle changes.^[5]

The presence of significant fibrosis changes the picture considerably. As fibrosis progresses from stage F2 (moderate) to F3 (severe) and eventually to F4 (cirrhosis), the risk of liver-related complications increases substantially. People who develop cirrhosis from MASH face a much higher risk of liver failure and liver cancer. In these advanced cases, liver transplantation may become necessary, and MASLD has become the leading reason for liver transplants in many countries, including Australia and the United States.^[3]^[19]

The good news is that early detection and intervention can significantly alter the course of the disease. Many patients who commit to lifestyle changes, manage their metabolic conditions like diabetes and high blood pressure, and work closely with their healthcare providers can prevent progression to advanced disease. This is why screening for people with risk factors and regular monitoring of those diagnosed with MASLD is so important for long-term health outcomes.

#1 Clinical Trials Search in Europe

Metabolic dysfunction-associated liver disease – Diagnostics

Introduction: Who Should Seek Diagnostic Testing